国际皮肤性病学杂志    2005 31 (1): 6-8   ISSN: 2096-5540  CN: 32-1880/R   儿童真菌病的系统治疗进展 李筱芳, 刘维达 中国医学科学院、中国协和医科大学皮肤病研究所 南京 210042 收稿日期 2003-11-03  修回日期 null  网络版发布日期 null 参考文献  [1] Pomeranz AJ, Sabnis SS. Tinea capitis:epidemiology, diagnosis and management strategies. Paediatr Drugs, 2002, 4:779-783. [2] Gupta AK, Cooper EA, Lynde CW. The efficacy and safety of terbinafine in children. Dermatol Clin, 2003, 21:511-520. [3] Gupta AK, Adam P. Terbinafine pulse therapy is effective in tinea capitis. Pediatr Dermatol, 1998, 15:56-58. [4] Lipozencic J, Skerlev M, Orofino-Costa R, et al. A randomized,double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol, 2002, 146:816. [5] Koumantaki E, Kakourou T, Rallis E, et al. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis. Pediatr Dermatol, 2001, 18:339-342. [6] Ungpakorn R, Ayutyanont T, Reangchainam S, et al. Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine. Clin Exp Dermatol, 2004, 29:300-303. [7] Gupta AK, Cooper EA, Ginter G. Efficacy and safety of itraconazole use in children. Dermatol Clin, 2003, 21:521-535. [8] Jahangir M, Hussain I, UI Hasan M, et al. A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis. Br J Dermatol, 1998, 139:672-674. [9] Gupta AK, Ginter G. Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis. Pediatr Dermatol, 2001, 18:519-522. [10] Gupta AK, Cooper EA, Montero-Gei F. The use of fluconazole to treat superficialfungal infections in children. Dermatol Clin, 2003, 21:537-542. [11] Valari M, Iordanidou A, Raftopoulou A, et al. Fluconazole in the treatment of pediatric tinea capitis caused by Microsporum canis.Drugs Exp Clin Res, 2002, 28:161-164. [12] Gupta AK, Dlova N, Taborda P, et al. Once weekly fluconazole is effective in children in the treatment of tinea capitis:a prospective,multicentre study. Br J Dermatol, 2000, 142:965-968. [13] Gupta AK, Adam P, Dlova N, et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species:griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol, 2001, 18:433-438. [14] Tosti A, Piraccini BM, Iorizzo M. Management of onychomycosis in children. Dermatol Clin, 2003, 21:507-509, [15] Gupta AK, De Rosso JQ. Management of onychomycosis in children.Postgrad Med, 1999, Spec No:31-37. [16] Huang PH, Paller AS. Itraconazole pulse therapy for dermatophyte onychomycosis in children. Arch Pediatr Adolesc Med, 2000, 154:614. [17] el-Mahallawy HA, Attia I, Ali-el-Din NH, et al. A prospective study on fungal infection in children with cancer. J Med Microbiol, 2002,51:601-605. [18] Herbrecht R, Auvrignon A, Andres E, et al. Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients. Ear J Clin Microbiol Infect Dis,2001, 20:77-82. [19] Walsh TJ, Lutsar I, Driscoll T,et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J, 2002, 21:240-248. [20] Sallmann S, Heilmann A, Heinke F, et al. Capofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease. Pediatr Infect Dis J, 2003, 22:199-200. [21] Rudy SJ. Superficial fungal infections in children and adolescents.Nurse Pract Forum, 1999, 10:56-66. 通讯作者: